I
I

Infineon

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

European stocks inch up as investors assess bond moves; oil stocks lag

* BASF rises on HSBC upgrade * Defensives gain * Heineken, Carlsberg to exit Russia * Oil stocks shed 2% as crude slides on China COVID surge (Updates to close, replaces comment) By Sruthi Shankar and Anisha Sircar March 28 (Reuters) - European shares gained on Monday, led by automakers and defensive sectors, as hopes for a peace deal between Russi
I
E
F
U
G

German stocks lead Europe higher as oil slides

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) March 28 (Reuters) - European shares rose on Monday, with a surge in automakers and chemical stocks boosting the German blue-chip index, while easing oil prices and hopes of a peace deal in the Ukraine crisis further lifted sentiment. The pa
I
E
F
U
G

Taiwan's UMC to spend $5 bln on new chip plant in Singapore

TAIPEI, Feb 24 (Reuters) - Taiwan's United Microelectronics Corp (UMC) 2303.TW will invest $5 billion on a new microchip factory in Singapore, with production expected to start in 2024 to support the boom in 5G and auto electronics, it said on Thursday. UMC, which has already been producing semiconductors in the country for more than 20 years, said
I
Q

European shares rebound from Monday sell-off as energy stocks, miners jump

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) * ING to quit French retail banking business * Sanofi's $1 bln Amunix buyout to add to drugmaker's pipeline * European chipmakers rise on Micron's quarterly beat * Bollore soars after $6.4 bln offer for African logistics assets (Updates to c
A
B
I
M
N
P
S
A
B
R
E
F
U
G

European stocks fall as Omicron worries rattle investors

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) * STOXX 600 gives back a chunk of Wednesdays gains * Apple suppliers hit by report on slowing demand * Vifor Pharma surges on takeover speculation (Updates to close) By Anisha Sircar and Susan Mathew Dec 2 (Reuters) - European shares fell mo
A
H
I
R
V
A
G
E
F
U

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.